14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jan 08, 2024 $189.29 $197.09 $185.01 $196.83 649 092
Jan 05, 2024 $190.33 $191.38 $188.45 $189.38 417 882
Jan 04, 2024 $189.68 $193.33 $188.38 $192.31 541 888
Jan 03, 2024 $193.96 $197.06 $190.43 $190.64 415 026
Jan 02, 2024 $189.88 $196.00 $189.71 $194.93 348 607
Dec 29, 2023 $195.43 $197.02 $191.14 $191.41 269 716
Dec 28, 2023 $196.87 $198.00 $195.18 $195.71 446 123
Dec 27, 2023 $191.43 $196.75 $191.00 $196.57 444 770
Dec 26, 2023 $192.67 $194.89 $190.23 $191.20 305 731
Dec 22, 2023 $183.05 $191.73 $181.67 $191.02 572 609
Dec 21, 2023 $180.83 $182.87 $180.33 $181.14 270 946
Dec 20, 2023 $187.01 $187.01 $178.86 $179.05 646 820
Dec 19, 2023 $187.51 $190.95 $187.06 $187.50 534 322
Dec 18, 2023 $185.63 $189.03 $185.50 $186.23 393 138
Dec 15, 2023 $187.03 $189.92 $183.06 $185.24 1 141 121
Dec 14, 2023 $183.68 $190.98 $183.08 $186.48 1 405 257
Dec 13, 2023 $173.63 $180.94 $173.05 $180.52 782 327
Dec 12, 2023 $172.29 $175.20 $169.83 $173.88 433 048
Dec 11, 2023 $170.04 $173.00 $168.85 $170.92 539 473
Dec 08, 2023 $175.03 $175.03 $170.00 $170.04 452 039
Dec 07, 2023 $176.22 $177.77 $174.39 $177.26 587 715
Dec 06, 2023 $171.00 $176.26 $169.60 $175.02 658 734
Dec 05, 2023 $171.98 $172.00 $169.44 $170.37 246 473
Dec 04, 2023 $170.81 $173.49 $169.77 $172.87 387 361
Dec 01, 2023 $167.93 $171.42 $166.02 $171.41 366 015
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT